Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bactraemia: Analytical strategy using propensity scores

Clinical Microbiology and Infection

Volumn 12, Issue 1, 2006, Pages 13-21

  Kim, S H ^a   Park, W B ^a   Lee, C S ^a   Kang, C I ^a   Bang, J W ^a   Kim, H B ^a   Kim, N J ^a   Kim, E C ^a,b   Oh, M D ^a,b   Choe, K W ^a,b  

^a Seoul National University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Bacteraemia; Empirical therapy; Outcome; Propensity score; Staphylococcus aureus

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CLINDAMYCIN; METICILLIN; NAFCILLIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MULTIVARIATE ANALYSIS; PENICILLIN RESISTANCE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

STAPHYLOCOCCUS AUREUS;

EID: 33644862512     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01294.x     Document Type: Article

References (41)

1. Boyce JM. Should we try vigorously to contain and control MRSA? Infect Control Hosp Epidemiol 1991; 12: 70-74.
2. Fridkin SK, Edwards JR, Courval JM et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units. Ann Intern Med 2001; 135: 175-183.
3. Smith TL, Pearson ML, Wilcox KR et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 340: 493-501.
4. Chang S, Sievert DM, Hageman JC et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003; 348: 1342-1347.
5. Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 1998; 19: 32-37.
6. Lodise TP, McKinnon PS, Swiderski L et al. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 1418-1423.
7. Soriano A, Martínez JA, Mensa J et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000; 30: 368-373.
8. Roghmann MC. Predicting methicillin resistance and the effect of inadequate empirical therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 2000; 160: 1001-1004.
9. Fowler VG, Olsen MK, Corey GR et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163: 2066-2072.
10. Melzer M, Eykyn SJ, Gransden WR et al. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Clin Infect Dis 2003; 37: 1453-1460.
11. Fätkenheuer G, Preuss M, Salzberger B et al. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2004; 23: 157-162.
12. Braitman L, Rosenbaum P. Rare outcomes, common treatments: Analytic strategies using propensity scores. Ann Intern Med 2002; 137: 693-695.
13. Durack DT. Evaluating and optimizing outcomes of surgery for endocarditis. JAMA 2003; 290: 3250-3251.
14. Joffe M, Rosenbaum P. Invited commentary: Propensity scores. Am J Epidemiol 1999; 150: 327-333.
15. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis. A propensity analysis. JAMA 2003; 290: 3207-3214.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 8th edn. Approved standard M100-S13 (M2). Wayne, PA: NCCLS, 2003.
17. Kim SH, Park WB, Lee KD et al. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Clin Infect Dis 2003; 37: 794-799.
18. McCabe WR, Jackson GG. Gram negative bacteremia 1. Etiology and ecology. Arch Intern Med 1962; 110: 847-855.
19. Romero-Vivas J, Rubio M, Fernandez C et al. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21: 1417-1423.
20. Lesens O, Methlin C, Hansmann Y et al. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: A prospective study using the Charlson weighted index of comorbidity. Infect Control Hosp Epidemiol 2003; 24: 890-896.
21. Gopal AK, Fowler VG, Shah M et al. Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. J Clin Oncol 2000; 18: 1110-1115.
22. Carmeli Y, Castro J, Eliopoulos GM et al. Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam. Antimicrob Agents Chemother 2001; 45: 275-279.
23. Carmeli Y, Eliopoulos GM, Mozaffari E et-al. Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 2002; 162: 2223-2228.
24. Katz MH. Performing the analysis. In: Katz MH, ed. Multivariable analysis. A practical guide for clinicians, 1st edn. New York: Cambridge University Press, 1999; 84-117.
25. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127: 757-763.
26. Harbarth S, Garbino J, Pugin J et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115: 529-535.
27. Connors AF, Speroff T, Dawson NV et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 1996; 276: 889-897.
28. Polanczyk CA, Rohde LE, Goldman L et al. Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery. JAMA 2001; 286: 309-314.
29. Garnacho J, Sole-Violan J, Sa-Borges M et al. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: A matched cohort study. Crit Care Med 2003; 31: 2478-2482.
30. Kollef MH. The importance of appropriate initial antibiotic therapy for hospital-acquired infections. Am J Med 2003; 115: 582-584
31. Pelletier SJ, Crabtree TD, Gleason EG et al. Waiting for microbiologic data to direct therapy against nosocomial infections in febrile surgical patients. Arch Surg 1999; 134: 1300-1308.
32. Feld R. Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: Pros and cons. Clin Infect Dis 1999; 29: 503-507.
33. Elting LS. Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997; 25: 247-249.
34. Ramphal R, Bolger M, Oblon DJ et al. Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: A randomized prospective study. Antimicrob Agents Chemother 1992; 36: 1062-1067.
35. Rubin M, Hathorn JW, Marshall D et al. Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia. Ann Intern Med 1988; 108: 30-35.
36. Yu V.L. Chiou C.C. Feldman C. et al. An international prospective study of pneumococcal bacteremia: Correlation with in vitro resistance, antibiotics administered, and clinical outcome Clin Infect Dis 2003 37 230-237
37. Garnacho-Montero J, Garcia-Garmendia J, Barrero-Almodovar A et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003; 31: 2742-2751.
38. Kim SH, Park WB, Lee KD et al. Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2004; 54: 489-497.
39. Moss RR, Humphries KH, Gao M et al. Outcome of mitral valve repair or replacement: A comparison by propensity score analysis. Circulation 2003; 108 (suppl II): 90-97.
40. Rubin DB, Thomas N. Matching using estimated propensity scores: Relating theory to practice. Biometrics 1996; 52: 249-264.
41. McDonald JR, Friedman ND, Stout JE, Sexton DJ, Kaye KS. Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med 2005; 165-313.